Long-term oxygen therapy (LTOT) is linked to reduced exacerbations and hospitalizations in COPD, ILD, and pulmonary hypertension.

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.

The HHS said it has taken the first step toward implementing most-favored-nation pricing for prescription drugs.

Suppressing REM sleep with antidepressants may increase survival in patients with amyotrophic lateral sclerosis.

Symptomatic children may have pulmonary embolism and/or deep vein thrombosis at similar rates to adults, despite current literature.

Measles is highly contagious among those who are unvaccinated and may have severe health consequences in children under age 5 ...

Physical activity levels have a significant association with a reduced incidence of restrictive spirometry patterns (RSP).

Having a previous SARS-CoV-2 infection provided a gradient of protection against reinfection, especially against severe forms of COVID-19.

The FDA has expanded the approval of the Freespira Breathing System to include the treatment of panic disorder and PTSD in ...

The FDA has approved Emrelis for the treatment of adult patients with locally advanced or metastatic NSCLC with high c-Met protein overexpression.

Increasing antibiotic treatment adherence among children lowered average treatment durations by up to 1.7 days.